Publicaciones en las que colabora con Stanisław Sław S. Gõźdź (24)

2020

  1. Endocrine treatment and incidence of relapse in women with oestrogen receptor-positive breast cancer in Europe: a population-based study

    Breast Cancer Research and Treatment, Vol. 183, Núm. 2, pp. 439-450

  2. Reasons for low cervical cancer survival in new accession European Union countries: a EUROCARE-5 study

    Archives of Gynecology and Obstetrics, Vol. 301, Núm. 2, pp. 591-602

2018

  1. Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries

    The Lancet, Vol. 391, Núm. 10125, pp. 1023-1075

2017

  1. Data quality in rare cancers registraton: The report of the RARECARE data quality study

    Tumori, Vol. 103, Núm. 1, pp. 22-32

  2. Erratum to “The histology of ovarian cancer: Worldwide distribution and implications for international survival comparisons (CONCORD-2)” [Gynecol. Oncol. 144 (2017) 405–413](S0090825816314974)(10.1016/j.ygyno.2016.10.019)

    Gynecologic Oncology

  3. Erratum to “Worldwide comparison of ovarian cancer survival: Histological group and stage at diagnosis (CONCORD-2)” [Gynecol. Oncol. 144 (2017) 396–404](S009082581631575X)(10.1016/j.ygyno.2016.11.019)

    Gynecologic Oncology

  4. The histology of ovarian cancer: worldwide distribution and implications for international survival comparisons (CONCORD-2)

    Gynecologic Oncology, Vol. 144, Núm. 2, pp. 405-413

  5. Worldwide comparison of ovarian cancer survival: Histological group and stage at diagnosis (CONCORD-2)

    Gynecologic Oncology, Vol. 144, Núm. 2, pp. 396-404

  6. Worldwide comparison of survival from childhood leukaemia for 1995–2009, by subtype, age, and sex (CONCORD-2): a population-based study of individual data for 89 828 children from 198 registries in 53 countries

    The Lancet Haematology, Vol. 4, Núm. 5, pp. e202-e217

2015

  1. Global surveillance of cancer survival 1995-2009: Analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2)

    The Lancet, Vol. 385, Núm. 9972, pp. 977-1010

  2. Prognoses and improvement for head and neck cancers diagnosed in Europe in early 2000s: The EUROCARE-5 population-based study

    European Journal of Cancer, Vol. 51, Núm. 15, pp. 2130-2143

2014

  1. Descriptive epidemiology of Kaposi sarcoma in Europe. Report from the RARECARE project

    Cancer Epidemiology, Vol. 38, Núm. 6, pp. 670-678

2013

  1. Descriptive epidemiology of sarcomas in Europe: Report from the RARECARE project

    European Journal of Cancer, Vol. 49, Núm. 3, pp. 684-695

  2. Rare neuroendocrine tumours: Results of the surveillance of rare cancers in Europe project

    European Journal of Cancer, Vol. 49, Núm. 11, pp. 2565-2578

2012

  1. Burden of testicular, paratesticular and extragonadal germ cell tumours in Europe

    European Journal of Cancer, Vol. 48, Núm. 2, pp. 159-169

  2. Carcinoma of endocrine organs: Results of the RARECARE project

    European Journal of Cancer, Vol. 48, Núm. 13, pp. 1923-1931

  3. Descriptive epidemiology of malignant mucosal and uveal melanomas and adnexal skin carcinomas in Europe

    European Journal of Cancer, Vol. 48, Núm. 8, pp. 1167-1175

  4. Embryonal cancers in Europe

    European Journal of Cancer, Vol. 48, Núm. 10, pp. 1425-1433

  5. Epidemiology of glial and non-glial brain tumours in Europe

    European Journal of Cancer, Vol. 48, Núm. 10, pp. 1532-1542

  6. Incidence and survival of rare urogenital cancers in Europe

    European Journal of Cancer, Vol. 48, Núm. 4, pp. 456-464